Sarepta Therapeutics (SRPT) had the highest return in 2012 by a large-cap US stock, returning 469.5%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Sarepta Therapeutics (SRPT) | 2012 | 469.54% |
Regeneron Pharmaceuticals (REGN) | 2012 | 202.73% |
PulteGroup (PHM) | 2012 | 180.68% |
Builders FirstSource (BLDR) | 2012 | 165.71% |
American Airlines (AAL) | 2012 | 159.62% |
Alnylam Pharmaceuticals (ALNY) | 2012 | 119.09% |
Insmed (INSM) | 2012 | 114.42% |
Genmab A-S (GMAB) | 2012 | 114.07% |
Cheniere Energy (LNG) | 2012 | 111.25% |
Expedia (EXPE) | 2012 | 110.28% |
Westlake Chemical (WLK) | 2012 | 104.76% |
Bank of America (BAC) | 2012 | 102.89% |
Nomura Holdings Inc ADR (NMR) | 2012 | 100.41% |
Lloyds Banking Group PLC ADR (LYG) | 2012 | 97.52% |
Lennar (LEN) | 2012 | 93.77% |
Booz Allen Hamilton (BAH) | 2012 | 93.12% |
Lennar (LEN.B) | 2012 | 91.21% |
Seagate Technology (STX) | 2012 | 90.71% |
LyondellBasell Industries (LYB) | 2012 | 89.63% |
Marathon Petroleum (MPC) | 2012 | 87.16% |
Smurfit WestRock (SW) | 2012 | 83.21% |
Illumina (ILMN) | 2012 | 79.32% |
Corpay (CPAY) | 2012 | 79.01% |
Saia (SAIA) | 2012 | 78.81% |
Guidewire Software (GWRE) | 2012 | 77.43% |
Large-cap stocks are treated as having a market cap of $10B+.
